Literature DB >> 1290924

Tachyphylaxis to capsaicin-induced cough and its reversal by indomethacin, in patients with the sinobronchial syndrome.

M Fujimura1, Y Kamio, S Sakamoto, T Bando, S Myou, T Matsuda.   

Abstract

Cough reflex testing with capsaicin has been used to study the pathophysiology of the cough reflex and the antitussive effects of various drugs. Although the reproducibility of capsaicin-induced cough has been well established in normal subjects, it is not known if prior challenge with capsaicin reduces the subsequent cough response to inhaled capsaicin in patients with the sinobronchial syndrome, a condition characterized by chronic upper and lower airway inflammation. Measurement of the capsaicin cough threshold, defined as the lowest concentration of capsaicin eliciting five or more coughs, was repeated four times at intervals of 15, 30 and 60 min in eleven patients with the SBS and ten normal subjects. The cough thresholds at 15, 30 and 60 min were greater than the initial value in patients with the SBS but not in normal subjects. In addition, we examined the effect of 4 days treatment with indomethacin (100 mg/day) on the cough thresholds measured twice at an interval of 15 min in eight patients with the SBS. Indomethacin increased the initial cough threshold and reduced the increment in the post-15 min cough threshold from the initial value compared with placebo, thus reducing the tachyphylaxis. These results indicate that chronic airway inflammation may be responsible for the decreased response (tachyphylaxis) to repeated inhalation of capsaicin, and suggest that cyclooxygenase products released by the airway inflammation may be involved in tachyphylaxis, cough receptor sensitivity to inhaled capsaicin, or both, in patients with the SBS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1290924     DOI: 10.1007/bf01831398

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  21 in total

1.  Effects of methacholine induced bronchoconstriction and procaterol induced bronchodilation on cough receptor sensitivity to inhaled capsaicin and tartaric acid.

Authors:  M Fujimura; S Sakamoto; Y Kamio; T Matsuda
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

2.  Receptors in the trachea and bronchi of the cat.

Authors:  J G WIDDICOMBE
Journal:  J Physiol       Date:  1954-01       Impact factor: 5.182

Review 3.  Physiology and treatment of cough.

Authors:  R W Fuller; D M Jackson
Journal:  Thorax       Date:  1990-06       Impact factor: 9.139

4.  Sulindac and cough induced by converting enzyme inhibitors.

Authors:  M G Nicholls; N L Gilchrist
Journal:  Lancet       Date:  1987-04-11       Impact factor: 79.321

5.  Sex difference in the inhaled tartaric acid cough threshold in non-atopic healthy subjects.

Authors:  M Fujimura; S Sakamoto; Y Kamio; T Matsuda
Journal:  Thorax       Date:  1990-08       Impact factor: 9.139

6.  Effect of inhaled procaterol on cough receptor sensitivity to capsaicin in patients with asthma or chronic bronchitis and in normal subjects.

Authors:  M Fujimura; S Sakamoto; Y Kamio; T Bando; K Kurashima; T Matsuda
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

Review 7.  Information arising from the tracheobronchial tree of mammals.

Authors:  G Sant'Ambrogio
Journal:  Physiol Rev       Date:  1982-04       Impact factor: 37.312

8.  Location of stretch receptors in the trachea and bronchi of the dog.

Authors:  D Bartlett; P Jeffery; G Sant'ambrogio; J C Wise
Journal:  J Physiol       Date:  1976-06       Impact factor: 5.182

9.  Capsaicin inhalation in man and the effects of sodium cromoglycate.

Authors:  J G Collier; R W Fuller
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

10.  Sensitivity of the human cough reflex: effect of inflammatory mediators prostaglandin E2, bradykinin, and histamine.

Authors:  N B Choudry; R W Fuller; N B Pride
Journal:  Am Rev Respir Dis       Date:  1989-07
View more
  1 in total

1.  Additive effect of continuous low dose ofloxacin on erythromycin therapy for sinobronchial syndrome.

Authors:  M Fujimura; Y Ishiura; M Saito; K Shibata; M Nomura; Y Nakatsumi; T Matsuda
Journal:  Drugs       Date:  1995       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.